2022
DOI: 10.1016/j.jval.2021.11.431
|View full text |Cite
|
Sign up to set email alerts
|

POSB158 Cost-Effectiveness of Obinutuzumab Combined with Chemotherapy As Induction Therapy and Followed By Obinutuzumab Maintenance Therapy for Treatment Naïve Patients with Advanced Follicular Lymphoma in Mainland China

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles